2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Sammaritano L, Askanase A, Bermas B, Dall'Era M, Duarte‐García A, Hiraki L, Rovin B, Son M, Alvarado A, Aranow C, Barnado A, Broder A, Brunner H, Chowdhary V, Contreras G, Felix C, Ferucci E, Gibson K, Hersh A, Izmirly P, Kalunian K, Kamen D, Rollins B, Smith B, Thomas A, Timlin H, Wallace D, Ward M, Azzam M, Bartels C, Cunha J, DeQuattro K, Fava A, Figueroa‐Parra G, Garg S, Greco J, Cuéllar‐Gutiérrez M, Iyer P, Johannemann A, Jorge A, Kasturi S, Kawtharany H, Khawandi J, Kirou K, Legge A, Liang K, Lockwood M, Sanchez‐Rodriguez A, Turgunbaev M, Williams J, Turner A, Mustafa R. 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis. Arthritis & Rheumatology 2025, 77: 1115-1135. PMID: 40331662, DOI: 10.1002/art.43212.Peer-Reviewed Original ResearchManagement of lupus nephritisLupus nephritisAmerican College of Rheumatology (ACRTreatment decisionsLupus nephritis therapyBest practice statementsQuality of evidencePulse glucocorticoidsGlucocorticoid taperingImmunosuppressive agentsRenal responseRecommendations AssessmentNephritisAmerican CollegeVoting panelClinical situationsGRADE recommendationsIndividual patientsTherapyPractice statementsEvidence-basedPICO questionClinical questionsPICO formatSystematic literature review
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply